Journal
MOLECULAR AND CLINICAL ONCOLOGY
Volume 1, Issue 2, Pages 215-219Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/mco.2012.36
Keywords
deguelin; anti-tumorigenesis; apoptosis; cell cycle arrest; anti-angiogenesis
Categories
Funding
- National Natural Science Foundation of China [30873145]
Ask authors/readers for more resources
Deguelin is a natural compound of the flavonoid family products isolated from Derris trifoliata Lour. or Mundulea sericea (Leguminosae). It exhibited significant antitumorigenesis and anti-proliferative activity in various types of cancer both in vitro and in vivo. Deguelin induced cell apoptosis by blocking anti-apoptotic pathways, such as PI3K-Akt, IKK-I kappa B alpha-NF-kappa B and AMPK-mTOR-survivin, while inhibiting tumor cell propagation and malignant transformation through p27-cyclinE-pRb-E2F1 cell cycle control and HIF-1 alpha-VEGF anti-angiogenic pathways. In pre-clinical trials, deguelin markedly decreased the tumor incidence. These biological findings identified deguelin as a novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest and anti-angiogenesis for cancer chemoprevention and chemotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available